Thomas Klemond, MD, has been appointed interim CEO of Minneapolis-based Hennepin Healthcare, effective April 11.
Dr. Klemond joined the organization in 2017 as division director for palliative medicine and has spent the last three years as vice president of medical affairs and president of the medical staff, according to a health system news release.
He was appointed to the interim CEO role after Jennifer DeCubellis announced in March that she will step down after five years at the helm.
“It’s a privilege to see our Hennepin Healthcare team’s deep commitment to our community firsthand and to play my own role in advancing that mission through patient care,” he shared in the release. “I am honored to serve in the organization in this capacity because I believe wholeheartedly in our team, the work we do and in the important place we have in delivering patient care to our community.”
Ms. DeCubellis said in the release that Dr. Klemond “will have my full support as he transitions into this role. He will have the backing of a strong executive leadership team who will lead alongside him as Hennepin Healthcare carries out its goals and mission.”
Hennepin Healthcare includes a level 1 adult trauma center, level 1 pediatric trauma center and acute care hospital, as well as a clinic system with primary care clinics.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
